Pigmented hypertrichotic dermatosis with insulin-dependent diabetes (PHID) syndrome is a recently described autosomal recessive disorder associated with predominantly antibody negative, insulindependent diabetes mellitus. In order to identify the genetic basis of PHID and study its relationship with glucose metabolism, we performed homozygosity mapping in five unrelated families followed by candidate gene sequencing. Five loss-of-function mutations were identified in the SLC29A3 gene which encodes a member of a highly conserved protein family that transports nucleosides, nucleobases and nucleoside analogue drugs, hENT3. We show that PHID is allelic with a related syndrome without diabetes mellitus, H syndrome. The interaction of SLC29A3 with insulin signaling pathways was then studied using an established model in Drosophila melanogaster. Ubiquitous knockdown of the Drosophila ortholog of hENT3, dENT1 is lethal under stringent conditions; whereas milder knockdown induced scutellar bristle phenotypes similar to those previously reported in the knockdown of the Drosophila ortholog of the Islet gene. A cellular growth assay showed a reduction of cell size/number which could be rescued or enhanced by manipulation of the Drosophila insulin receptor and its downstream signaling effectors, dPI3K and dAkt. In summary, inactivating mutations in SLC29A3 cause a syndromic form of insulin-dependent diabetes in humans and in Drosophila profoundly affect cell size/number through interactions with the insulin signaling pathway. These data suggest that further investigation of the role of SLC29A3 in glucose metabolism is a priority for diabetes research.
INTRODUCTION
Although Mendelian inheritance of insulin-dependent diabetes is rare, the characterization of gene mutations in families with disorders such as transient neonatal diabetes and maturity-onset diabetes of the young has contributed significantly to our understanding of the genetic architecture of glucose metabolism (1,2). We have recently described an autosomal recessive disorder characterized by the childhood onset of pigmented hypertrichotic skin lesions associated with an 83% frequency of predominantly autoantibody negative insulin-dependent diabetes mellitus (PHID syndrome) (3, 4) . Overlapping dermatological features have been reported in a childhood onset variant of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS syndrome), and in a syndrome of hyperpigmentation, hypertrichosis, hepatosplenomegaly, heart anomalies, hearing loss, hypogonadism, low height and hyperglycemia (H syndrome) (5, 6) . It is of interest that diabetes mellitus (DM) is observed at a very high frequency in the PHID cohort (five of six cases) compared with its absence among 15 cases of H syndrome. Children with PHID typically develop autoantibodynegative DM in late childhood or early puberty, presenting with diabetic ketoacidosis requiring on-going insulin therapy. Circulating insulin was not detectable and could not be induced in response to glucose administration, consistent with a defect of insulin production or secretion rather than insulin resistance. Two affected siblings in one family also developed severe exocrine pancreas insufficiency (4) . In contrast, the phenotype of H syndrome includes severe clinodactyly and deafness, which are absent in PHID (Supplementary Material, Tables). The two disorders share in common the dermatological features of patches and plaques of hyperpigmented and hypertrichotic skin, the histological features of polyclonal perivascular lymphohistiocytic infiltration with numerous plasma cells in the dermis and subcutis.
Given the potential significance of the identification of a novel interactor with the insulin pathway, we determined the genetic basis of PHID syndrome and sought to identify whether the identified gene interacted with the insulin signaling pathway through the use of an animal model. Drosophila melanogaster was the chosen model owing to the availability of extensive genetic resources for stably altering the expression of genes of interest, and that components of the insulin signaling pathway are highly conserved and well-studied in flies (7) . Drosophila contains seven insulin-like peptides (dILPs), some of which are released into circulation in response to nutrients (8, 9) . Studies of downstream insulin signaling components have shown that this pathway is important in the regulation of nutrient metabolism and in the developmental response of flies to fluctuations in nutrient availability (10 -12) . At the cellular level, Drosophila insulin signaling components are important in the regulation of cellular growth and proliferation, a function of insulin that is also conserved in humans, and which is the basis for the developmental assay performed in this study. All of the dILPS have been shown to positively regulate growth during fly development (8, 9) , as have fly homologues of downstream insulin signaling components including the Drosophila insulin receptor (dInR), the insulin receptor substrate (chico), phosphoinositide-3-kinase (dPI3K) and Akt (dAkt) (7) . In contrast, negative regulation of the pathway has been shown to reduce growth (7) .
We provide the first evidence that mutations in the human SLC29A3 gene cause a Mendelian disorder associated with insulin-dependent diabetes mellitus and pigmented hypertrichotic skin lesions and show that it is allelic with H syndrome. Furthermore, we show that the Drosophila ortholog of this gene interacts with components of the insulin signaling pathway through the use of a developmental assay that is indicative of alterations in cell growth or proliferation.
RESULTS

Gene and mutation identification
Analysis of the single nucleotide polymorphism (SNP) microarray genotypes from six patients with PHID identified a single common 1.4 Mb region of shared homozygosity within cytogenetic band 10q22.1, between SNPs rs10509321 and rs1900515 (Fig. 1A) . Inspection of the Ensembl and UCSC Genome Browsers demonstrated that the region included 14 known and predicted genes: ADAMTS14, C10orf27, CDH23, EIF4EBP2, LRRC2, KIAA1274, NODAL, NPFFR1, PCBD1, PPA1, PRF1, SLC29A3, SGPL1, UNC5B. Positional candidate genes were selected for sequencing in order to identify pathogenic mutations (Fig. 1B) . Five different homozygous mutations were identified in the SLC29A3 gene encoding the equilibrative nucleoside transporter 3 (Fig. 1C , Table 1 ). Human ENT3 has been shown recently to be the cause of H syndrome, an autosomal recessive disorder with overlapping skin features to PHID (6) , indicating that these are allelic disorders. hENT3 belongs to a structurally unique protein family of nucleoside and/or nucleobase transporters (13, 14) . The five homozygous mutations identified segregated with the disease within each family and were not present in over 100 Lebanese and Pakistani control chromosomes.
Two novel homozygous mutations predicted to cause premature protein truncation were identified, a 1 bp deletion c.940delT and a nonsense mutation c.1330G.T. The deletion causes a frame shift mutation p.Y314Tfs in transmembrane domain 7 and is predicted to result in the substitution of transmembrane domains 8 -11 with an irrelevant protein sequence of 91 amino acids derived from an alternate reading frame. The nonsense mutation p.E444X is predicted to lead to premature protein truncation with loss of part of the final cytoplasmic domain and transmembrane domain 11 of hENT3. It would appear unlikely that the either residual protein would be capable of nucleoside transport function.
Three homozygous missense mutations of SLC29A3 were identified to involve conserved amino acids ( Table 1 ). The first missense mutation involves Methionine116 in transmembrane domain 2, which is a hydrophobic amino acid in species as distantly related as humans and nematodes, with a large basic amino acid, Arginine (p.M116R; Fig. 1C and E). The Grantham score for this substitution is 91, which is classified as a moderate change (15) . Analysis using the SIFT prediction software also classifies this as a likely deleterious change (16) . The introduction of a large basic amino acid into a transmembrane domain would likely result in significant disruption of the hydrophobic nature of the domain and result in retention of the transporter protein within the endoplasmic reticulum, as has been demonstrated for other membrane proteins (17) .
The second missense change is a recently reported Glycine to Arginine substitution at hENT3 amino acid 437 (p. G437R  Fig. 1C ), which is located in the putative cytoplasmic domain between transmembrane domains 10 and 11. This is the only mutation in the PHID cohort that is shared with the known mutations in H syndrome. Of particular interest is the observation that this is the sole individual in the PHID cohort who has not developed insulin-dependent DM. The p.G437R change involves the substitution of a large basic amino acid at a position where 41 members of the ENT family as distantly related as humans and Arabidopsis thaliana encode a small hydrophobic amino acid (Fig. 1E) (18) . The Grantham difference for this change is 125 and is classified as a moderately radical change.
The third missense change occurs at hENT3 amino acid residue 449, which is also located in the final putative intracellular domain between transmembrane domains 10 and 11, and involves the substitution of a Threonine by an Arginine (p.T449R). The amino acids encoded at this position in hENT3 orthologs are small polar/uncharged or small hydrophobic residues (Fig. 1E ). Substitution by arginine is associated with a Grantham score of 71 and is predicted by SIFT as not to be tolerated.
RNA and protein studies in human cells
The cellular consequences of an hENT3 missense mutation were studied in representative patient fibroblasts who had a p.T449R mutation. Immunoblot analysis with antibodies to different N-terminal peptides of human and mouse ENT3 revealed a 52 kDa and a 58 kDa hENT3 band in patient and control fibroblasts ( Fig. 2A ) likely representing the nonglycosylated and N-glycosylated forms of hENT3, respectively. The level of hENT3-T449R protein in fibroblasts was found to be significantly lower than that of hENT3 in the control (30.1 + 17.5%, p ¼ 0.02). In order to address whether this decrease was due to altered stability of the hENT3 mRNA, real-time quantitative PCR of fibroblast mRNA was performed. hENT3 mRNA levels were reduced to 34% (p ¼ 0.0006) of the average expression level in fibroblasts from eight unrelated healthy control individuals. The reduced hENT3 protein level was also reflected in the immunocytochemistry of control and patient cells (Fig. 2B) .
The residual hENT3 protein showed an altered intracellular distribution. In control cells, the hENT3 transmembrane protein localizes to intracellular membrane compartments, as previously described (14) (Fig. 2B) . In contrast, the patient cells showed bright hENT3 foci that co-localized with LAMP-2 (lysosomal-associated membrane protein 2), a marker of late endosomal/lysosomal compartments. The accumulation of hENT3-T449R in LAMP-2-positive organelles despite the overall reduction in protein levels suggests that there may also be a defect of cellular trafficking. Taken together a combination of decreased protein levels, accumulation of mutant hENT3 in late endosomal/lysosomal compartments and the likely impaired functionality of the mutant protein may underlie this disorder.
Drosophila studies
To determine whether SLC29A3 has a role in the insulin signaling pathway, we studied the effects of altering the expression of the Drosophila ortholog of SLC29A3 during fly development. The ENT protein family is conserved in flies and consists of three members with the Drosophila ortholog of hENT3 being dENT1 as determined by the reciprocal BLAST best hit approach (see Supplementary Material, Table S3 and Fig. 1 ). The two proteins show 29% amino acid identity and 53% homology in an aligned region that includes the lysosomal targeting sequence and all 11 transmembrane regions (residues 26 to C-terminus). The expression of dENT1 was knocked down by RNA-interference (RNAi) using the conditional UAS-GAL4 system in combination with different promoter (Gal4) lines (19, 20) . The efficiency of the UAS-Gal4 system is temperature-dependent with greater induction of the dENT1 RNAi achieved at 288C than at 258C (21) .
Ubiquitous knockdown of dENT1 using a strong Act5C-Gal4 (25FO1) promoter at 288C resulted in 100% lethality during pupal and pharate adult stages (Fig. 3A) . Quantitative RT -PCR on knockdown larvae raised under these conditions revealed that dENT1 mRNA levels were reduced by half compared with wild-type (wt) (Fig. 3B) . When induction of the dENT1 RNAi was reduced by raising the flies at 258C, diminished viability was still apparent prior to adulthood (25.2% lethality, p ¼ 0.03). Further lethality occurred . hENT3 immunoblot signals were quantified after equalization for loaded protein using control b-actin levels. Control samples were set to 100% and relative expression levels for the patient expressed as a percentage of control levels.
after eclosion with 29% lethality observed within the first 3 days, compared with 0% lethality of non-knockdown siblings (Fig. 3D) . To demonstrate that lethality was due specifically to the partial loss of dENT1, viability was rescued by dENT1 re-expression with the same promoter, in the dENT1 RNAi background. The Drosophila EP-line w 1118 ; PfEPgEP2066 carries a transposon with an integrated UAS element that is inserted in the 5 0 -UTR of the dENT1 gene. Larvae carrying both the Act5C-Gal4 (25FO1) promoter in combination with the EP2066 (UAS-dENT1) insertion show a 10-fold increase in dENT1 mRNA levels (Fig. 3C) . The presence of the overexpression allele in the Act-Gal4-induced dENT1-RNAi background rescued viability defects caused by dENT1 knockdown (Fig. 3D ). These data demonstrate that even partial loss of dENT1 has a deleterious effect on Drosophila development and survival, with the percentage lethality being proportional to the induction of dENT1 knockdown.
Mild dENT1 knockdown flies that reached adulthood exhibited abnormal sensory bristle development. Two sensory bristle phenotypes were observed: abnormally short, thick bristles as well as ectopic bristles (Fig. 3E) . Despite the ubiquitous knockdown, these phenotypes manifested exclusively on the scutellum, a posterior extension of the fly thorax that carries four sensory bristles in a highly stereotypical pattern, and are similar to those previously reported with mutations of the Drosophila ortholog of the Islet gene (22) . At least one of the two abnormal bristle phenotypes was present in 58% of dENT1 knockdown flies (typically affecting the morphology of one or two bristles or generating one or two ectopic bristles per scutellum, Fig. 3E ), whereas variation of the normal scutellar bristle pattern occurred in only 4% of Act5C-Gal4 control siblings. Control flies that inherited the UAS-dENT1
RNAi without the Gal4 promoter showed an increased, but low incidence of bristle phenotypes (18%) suggesting that the RNAi transgene is active to a minor 
Arrows show abnormally short bristles (middle) and extra bristles (right). (F) MS1096-Gal4, UAS-dENT1
RNAi flies show an up-curled wing phenotype (middle) when compared to MS1096-Gal4 controls (left). The severity of this phenotype can be increased by co-expression of a dominant-negative form of dPI3K to produce a strongly up-curled wing phenotype (right). extent even in the absence of Gal4, in agreement with a mild reduction in mRNA level detected in the quantitative RT -PCR experiments (Fig. 3B) . The bristle phenotype could also be rescued by UAS-dENT1 re-expression with an observed reduction from 58% to 32%. dENT1 knockdown was then targeted to the wings, tissues not essential for viability, to enable further study of interactions with the insulin signaling pathway. The wing disk is an ectodermal-derived pouch consisting of dorsal and ventral epithelial sheaths, which give rise to the two surfaces of the adult wing blade (23) . This system has been used to investigate insulin signaling component interactions, which are known to regulate cell growth and proliferation (24) . Knockdown of dENT1 in the dorsal wing disc by genetic combination of UAS-ENT1
RNAi and the MS1096-Gal4 promoter line produced an up-curled wing phenotype in more than 93% of animals (Fig. 3F, Table 2 ). This wing phenotype was absent in control siblings that carried either the UAS-ENT1
RNAi construct or the MS1096-Gal4 promoter construct alone (Fig. 3F) . The MS1096 promoter expresses Gal4 in the dorsal sheath of the developing wing imaginal disc, thus an up-curled wing indicates reductions in cell size or number in the targeted tissue.
We then tested whether components of the insulin signaling pathway were able to modify the dENT1 RNAi-induced up-curled wing phenotype. Ectopic over-expression of dInR, dPI3K and dAkt in the dorsal wing caused a down-curl of the wing in 95.5%, 5.5% and 53.2% of flies, respectively ( Table 2) . Expression of dInR, dPI3K and dAkt in the presence of dENT1 knockdown resulted in rescue of the dENT1 RNAi-induced up-curled wing phenotype, with 82.5%, 59.5% and 92.3% of flies showing a wild-type phenotype, respectively (Table 2 ). In contrast, inhibition of insulin signaling through expression of a dominant negative form of PI3K resulted in up-curled wings in 27.6% of flies (Table 2) . When combined with ENT1 knockdown, 100% of progeny exhibited a strongly up-curled wing phenotype (Table 2 ; representative image in Fig. 3F ). Taken together, these data are consistent with dENT1 being a positive promoter of cell size or number that acts synergistically with the insulin signaling pathway.
DISCUSSION
We have identified mutations in the equilibrative nucleoside transporter 3 protein that are associated with an inherited syndrome of insulin-dependent DM, and provide prima facie evidence that the Drosophila ortholog of this protein interacts with the insulin signaling pathway. This is the first evidence that mutations in the human SLC29A3 gene can be associated with a diabetic phenotype.
hENT3 is a 475-amino acid protein that transports hydrophilic nucleosides, nucleobases and nucleoside analogue drugs across cell membranes (13, 14) . Indeed, hENT3 has been demonstrated to bind nucleosides in vitro and transport nucleosides and nucleobases upon ectopic expression in Xenopus oocytes (14) . Based on sequence homology, it is a member of an ancient superfamily of nucleoside transport proteins represented in a wide variety of taxa including mammals, teleost fish, tunicates, insects, round worms and slime molds (18, 25) . In contrast to other members of the ENT gene family which are predominantly expressed as integral plasma membrane proteins, hENT3 is an integral membrane protein mainly localizing to intracellular organelles (26) . However, the subcellular localization of hENT3 has not been definitively assigned with data indicating that hENT3 may localize to acidic late endosomes, lysosomes and mitochondria (14, 27) . It has been proposed that hENT3 functions as a pH-dependent transporter of nucleosides across the lysosomal membrane (14) . The availability of a cytoplasmic pool of nucleosides is a key requirement for several cellular pathways, notably for the nucleoside salvage pathway (13) and in the generation of adenosine and guanosine triphosphates for cellular energy metabolism and signal transduction.
Ubiquitous loss of the Drosophila ortholog of SLC29A3 is semi-viable to lethal, depending on the degree of expression knockdown. The observation that dENT1 knockdown mutants die at multiple stages of development suggests that this protein, rather than being required for a specific developmental process, has crucial housekeeping or metabolic functions. When dENT1 expression was knocked down in the dorsal wing disk, an up-curved wing phenotype resulted, indicating a reduction of cell size or proliferation in the dorsum of Combinations of a dPI3K dominant negative allele and dENT1 knockdown
the wing. The counterpart phenotype of down-bending of the wing was also observed upon activation of positive regulators of insulin signaling in the dorsal wing (28) : this has been demonstrated to be due to increased proliferation of cells in that tissue. We show that ectopic expression of the insulin receptor, dPI3K and dAKT is able to rescue the up-curved wing phenotype caused by dENT1 knockdown, generating a normal-shaped wing. A concordant result was obtained in which the dENT1 phenotype was exaggerated by overexpression of a dominant negative form of dPI3K. Taken together with the clinical findings of predominantly autoantibody negative insulin-dependent DM in the majority of the patients in this cohort, these data support the hypothesis that SLC29A3 interacts with one or more components of the insulin signaling pathway. Despite human body hair and fly bristles sharing only limited functional features, ectopic bristles induced by loss of dENT1 expression are a striking phenotype in light of human hypertrichosis associated with PHID. Fly bristles have been predominantly studied to learn about human hair cell biology in the inner ear (29, 30) , but they also share some features with body hair follicle cells, including their differentiation from epithelial cells involving similar molecular mechanisms such as Delta/Notch-mediated lateral inhibition (29, 31) . A role for dENT1 in the regulation of Drosophila bristle development has also been observed in other studies. In a large-scale Drosophila over-expression study, over-expression of dENT1 in proneural clusters (where the abovementioned differentiation from epithelial cells and lateral inhibition takes place) causes loss of sensory bristles (32) , suggesting that dENT1 indeed functions as a crucial regulator of bristle development. Why ubiquitous knockdown of dENT1 induces ectopic bristles only on the scutellum remains elusive, but resembles scutellum-restricted bristle phenotypes caused by inactivation of the Drosophila ortholog of the Lim-Homeodomain transcription factor Islet-1, an essential regulator of pancreatic morphogenesis in humans (22) . The human hypertrichosis phenotype also occurs in restricted, rather stereotyped areas, and not over the entire body.
The clinical phenotypes of PHID and H syndrome are distinguished by the minimal overlap between mutations in the PHID syndrome cohort (five different mutations in five families) and those in H syndrome and POEMS (three mutations in 10 families) (see Supplementary Material, Tables). Phenotypic heterogeneity is an interesting and imperfectly understood problem in genetics. It is clear that in some instances it may arise owing to mutational class differences (in-frame versus out-of-frame mutations, whole gene and multi-exon deletions versus point mutations), or to variation in mutation position with respect to functional domains of proteins. In some instances identical mutations can give rise to different clinical phenotypes, such as Pfeiffer or Crouzon syndrome both of which may be associated with mutations of c.1036T.C, c.1037G.A in FGFR2, suggesting that genetic background, functional redundancy and/or environmental effects also contribute to the observed variation. We speculate that there may be genotype, genetic background or environment-specific risks for the development of the distinguishing clinical features of PHID (diabetes mellitus) and the allelic disorder H syndrome (deafness); however, the analysis of many additional cases will be required to investigate this further. As the clinical management issues for patients with PHID and H syndromes are significantly different, we suggest that these disorders should be considered as different allelic entities until further information is available.
In summary, we have associated mutations in the SLC29A3 gene with diabetes mellitus in humans and the insulin signaling pathway in Drosophila. The mechanistic basis of these findings remains to be determined. This is strong evidence supporting the investment of resources to further investigate the role of SLC29A3 and its orthologs in diabetes and glucose metabolism in model systems.
MATERIALS AND METHODS
Subjects
The affected children were identified as a result of the publication of the clinical phenotype of PHID, principally by direct contact with a senior clinician (J.P.). Consent for genetic testing was obtained following local clinical guidelines. Five unrelated families of diverse ethnic origins (one North American Caucasian, one Indian, one Pakistani and two Australian Lebanese) of which four were known to be consanguineous, were studied using SNP microarrays. Families A-D were analyzed with a 50 K and two affected siblings in family E with a 10 K SNP array. Regions of excess homozygosity were identified using an algorithm adapted from Woods et al. (33) , which calculated the number of contiguous homozygous SNPs required for significance in relation to degree of consanguinity for each individual. Some leeway was permitted for the presence of heterozygous SNPs interrupting long homozygous segments to allow for signal miscalls and de novo mutations. Identity by descent was defined as regions where this significance reached a threshold of p , 0.001.
Mutation analysis
PCR and DNA sequencing primers for the genes in the region were designed based on Genbank reference sequences (primer sequences available on request). PCR was performed in 10 ml with Invitrogen Platinum w PCR Supermix, 50 ng genomic DNA, and 1.5 pmol of forward and reverse primers. Thermocycling conditions were initial denaturation at 958C/3 min followed by 31 cycles (528C/10 s, 568C/10 s, 608C/20 s, 728C/ 30 s, 958C/30 s), and final extension 728C/7 min. PCR products were cycle-sequenced and analyzed on an ABI 3130xl Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). DNA sequence and mutation analyses were performed using Mutation Surveyor v2.51 (SoftGenetics), Alamut v1.31e (Interactive Biosoftware), NNSPLICE 0.9 (34, 35) .
Immunoblotting
Patient and control (wild-type) fibroblasts were cultured in Dulbecco's modification of Eagle's medium supplemented with 10% fetal bovine serum, glutamine, penicillin, streptomycin at 378C in 5% CO 2 . Protein samples were extracted from 10 4 human fibroblasts and subjected to immunoblotting as described previously (36) . The primary antibodies used were a 1:1000 dilution of goat anti-Ent3 peptide antibodies (N18 or N20, Santa Cruz Biotechnology, Delaware, CA, USA). As secondary antibodies, 1:2000 horseradish peroxidaseconjugated rabbit anti-goat antibodies were used (Dako, Glostrup, Denmark).
Immunocytochemistry
Patient and control fibroblasts at 50% confluency were fixed with 3% paraformaldehyde and immunocytochemistry performed as described previously (37) . Primary antibodies were 1:50 diluted goat anti-hEnt3, 1:100 diluted rabbit anti-calnexin (a gift of I. Braakman, Utrecht, The Netherlands) or 1:200 diluted mouse anti-lysosome-associated membrane protein 2 (LAMP-2; AbD Serotec, Oxford, UK). Secondary antibodies were 1:100 diluted goat anti-rabbit and goat antimouse, both conjugated to Alexa-594, or chicken anti-goat antibodies conjugated to Alexa-488 (Invitrogen, Paisley, UK). Images were obtained by confocal scanning microscopy using an Olympus FluoView1000 microscope (Olympus Europa GMBH, Hamburg, Germany).
Quantitative polymerase chain reaction
Fibroblast total RNA was isolated from blood using the PAXgene Blood RNA kit (QIAGEN, Venlo, The Netherlands) following the manufacturer's protocol. For analysis of dENT1 knockdown efficiency in Drosophila, RNA was extracted in triplicate from third instar larvae of the following genotypes (i) w 1118
